Received Oct 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | 7kd5b | — |
Swelling of face; This non-serious case was reported by a consumer and described the occurrence of facial swelling in a 52-year-old female patient who received DTPa (Reduced antigen) (Tdap Vaccine) (batch number 7kd5b, expiry date 14-JUN-2027) for prophylaxis. Additional patient notes included Patient never had an adverse reaction before. On 23-SEP-2025, the patient received Tdap Vaccine .5 ml. On 24-SEP-2025, 1 days after receiving Tdap Vaccine, the patient experienced facial swelling (Verbatim: Swelling of face). The outcome of the facial swelling was not resolved. It was unknown if the reporter considered the facial swelling to be related to Tdap Vaccine. It was unknown if the company considered the facial swelling to be related to Tdap Vaccine.
Comments: Patient never had an adverse reaction before